| Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing BW Kunkle, B Grenier-Boley, R Sims, JC Bis, V Damotte, AC Naj, ... Nature genetics 51 (3), 414-430, 2019 | 2470 | 2019 |
| Gut microbiome alterations in Alzheimer’s disease NM Vogt, RL Kerby, KA Dill-McFarland, SJ Harding, AP Merluzzi, ... Scientific reports 7 (1), 13537, 2017 | 1835 | 2017 |
| Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis Y Iturria-Medina, RC Sotero, PJ Toussaint, JM Mateos-Pérez, AC Evans Nature communications 7 (1), 11934, 2016 | 1079 | 2016 |
| Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease R Sims, SJ Van Der Lee, AC Naj, C Bellenguez, N Badarinarayan, ... Nature genetics 49 (9), 1373-1384, 2017 | 959 | 2017 |
| Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study GS Watson, BA Cholerton, MA Reger, LD Baker, SR Plymate, S Asthana, ... The American journal of geriatric psychiatry 13 (11), 950-958, 2005 | 789 | 2005 |
| Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial MW Dysken, M Sano, S Asthana, JE Vertrees, M Pallaki, M Llorente, ... Jama 311 (1), 33-44, 2014 | 770 | 2014 |
| Testosterone supplementation improves spatial and verbal memory in healthy older men MM Cherrier, S Asthana, S Plymate, L Baker, AM Matsumoto, E Peskind, ... Neurology 57 (1), 80-88, 2001 | 596 | 2001 |
| Plasma tau in Alzheimer disease N Mattsson, H Zetterberg, S Janelidze, PS Insel, U Andreasson, ... Neurology 87 (17), 1827-1835, 2016 | 517 | 2016 |
| Effects of hormone therapy on cognition and mood in recently postmenopausal women: findings from the randomized, controlled KEEPS–cognitive and affective study CE Gleason, NM Dowling, W Wharton, JAE Manson, VM Miller, ... PLoS medicine 12 (6), e1001833, 2015 | 502 | 2015 |
| Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose S Craft, S Asthana, JW Newcomer, CW Wilkinson, IT Matos, LD Baker, ... Archives of general psychiatry 56 (12), 1135-1140, 1999 | 441 | 1999 |
| In vivo staging of regional amyloid deposition MJ Grothe, H Barthel, J Sepulcre, M Dyrba, O Sabri, SJ Teipel, ... Neurology 89 (20), 2031-2038, 2017 | 423 | 2017 |
| Association of insulin resistance with cerebral glucose uptake in late middle–aged adults at risk for Alzheimer disease AA Willette, BB Bendlin, EJ Starks, AC Birdsill, SC Johnson, BT Christian, ... JAMA neurology 72 (9), 1013-1020, 2015 | 423 | 2015 |
| Insulin increases CSF Aβ42 levels in normal older adults GS Watson, ER Peskind, S Asthana, K Purganan, C Wait, D Chapman, ... Neurology 60 (12), 1899-1903, 2003 | 394 | 2003 |
| High-dose estradiol improves cognition for women with AD: results of a randomized study S Asthana, LD Baker, S Craft, FZ Stanczyk, RC Veith, MA Raskind, ... Neurology 57 (4), 605-612, 2001 | 372 | 2001 |
| The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer’s disease NM Vogt, KA Romano, BF Darst, CD Engelman, SC Johnson, ... Alzheimer's research & therapy 10, 1-8, 2018 | 365 | 2018 |
| Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease S Palmqvist, H Zetterberg, N Mattsson, P Johansson, ... Neurology 85 (14), 1240-1249, 2015 | 355 | 2015 |
| Testosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairment MM Cherrier, AM Matsumoto, JK Amory, S Asthana, W Bremner, ... Neurology 64 (12), 2063-2068, 2005 | 348 | 2005 |
| Insulin dose–response effects on memory and plasma amyloid precursor protein in Alzheimer’s disease: interactions with apolipoprotein E genotype S Craft, S Asthana, DG Cook, LD Baker, M Cherrier, K Purganan, C Wait, ... Psychoneuroendocrinology 28 (6), 809-822, 2003 | 346 | 2003 |
| Ferritin levels in the cerebrospinal fluid predict Alzheimer’s disease outcomes and are regulated by APOE S Ayton, NG Faux, AI Bush Nature communications 6 (1), 6760, 2015 | 320 | 2015 |
| Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer’s disease: results of a placebo-controlled, double-blind, pilot study S Asthana, S Craft, LD Baker, MA Raskind, RS Birnbaum, CP Lofgreen, ... Psychoneuroendocrinology 24 (6), 657-678, 1999 | 318 | 1999 |
